← Back to Search

Run-In Sessions 1-5 for Non-Small Cell Lung Cancer

N/A

Waitlist Available

Led By Lara Traeger, Ph.D

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up week 12

Awards & highlights

Study Summary

This trial will develop and test a new care program to help lung cancer patients improve their quality of life after treatment.

Eligible Conditions

Non-Small Cell Lung Cancer
Mesothelioma
Small Cell Lung Cancer
Cognitive Behavioral Therapy

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ week 12

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~week 12

This trial's timeline: 3 weeks for screening, Varies for treatment, and week 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of participants enrolled

Number of participants retained

Proportion of intervention arm participants who complete study visits

Secondary outcome measures

Acceptability of study

Change in Fear of Cancer Recurrence Scale 7 score

Change in Functional Assessment of Cancer Therapy-Lung Cancer (FACT-L) score

+2 more

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Run InExperimental Treatment1 Intervention

Participants will receive a 5-session psychoeducational intervention, focused on skills to enhance post-treatment quality of life with attention to (a) managing expectations, (b) coping with uncertainty, (c) self-managing residual symptoms and (d) strengthening social support.

Group II: InterventionExperimental Treatment1 Intervention

Group III: ControlActive Control1 Intervention

Participants will receive a 1-session intervention, focused on reviewing goal progress for post-treatment quality of life, providing encouragement and support, identifying any current concerns, and providing tailored recommendations and resources.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor

2,928 Previous Clinical Trials

13,198,334 Total Patients Enrolled

Lara Traeger, Ph.DPrincipal Investigator - Massachusetts General Hospital

Massachusetts General Hospital

1 Previous Clinical Trials

80 Total Patients Enrolled

Media Library

Run-In Sessions 1-5 Clinical Trial Eligibility Overview. Trial Name: NCT04450043 — N/A

Non-Small Cell Lung Cancer Research Study Groups: Run In, Intervention, Control

Non-Small Cell Lung Cancer Clinical Trial 2023: Run-In Sessions 1-5 Highlights & Side Effects. Trial Name: NCT04450043 — N/A

Run-In Sessions 1-5 2023 Treatment Timeline for Medical Study. Trial Name: NCT04450043 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the expected outcome of this clinical trial?

"This 12-week clinical trial seeks to analyse the number of enrolled participants. Secondary objectives include a change in Hospital Anxiety and Depression Scale score (with higher scores indicating greater distress), Functional Assessment of Cancer Therapy-Lung cancer score (with higher scores representing better quality of life) and Multidimensional Scale of Perceived Social Support score (mean scores, with higher numbers meaning increased perceived support)."

Answered by AI

Are there any available spots still available for participation in this experiment?

"According to clinicaltrials.gov, this medical experiment is no longer recruiting patients. Initially posted on August 1st 2020 and last amended January 11th 2022, the trial has finished its recruitment period; although 2237 other trials are presently searching for candidates."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Transitions Project: Supporting Adults During the Shift From Cancer Treatment to Surveillance

Lara Traeger 2020. "The Transitions Project: Supporting Adults During the Shift From Cancer Treatment to Surveillance". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04450043.